Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues

Matthew R. Ramsey, Janakiraman Krishnamurthy, Xin-Hai Pei, Chad Torrice, Weili Lin, Daniel R. Carrasco, Keith L. Ligon, Yue Xiong, Norman E. Sharpless

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

Cell cycle progression from G1 to S phase depends on phosphorylation of pRb by complexes containing a cyclin (D type or E type) and cyclin-dependent kinase (e.g., cdk2, cdk4, or cdk6). Ink4 proteins function to oppose the action of cdk4/ 6-cyclin D complexes by inhibiting cdk4/6. We employed genetic and pharmacologic approaches to study the interplay among Ink4 proteins and cdk4/6 activity in vivo. Mouse embryo fibroblasts (MEF) lacking p16Ink4a and p18Ink4c showed similar growth kinetics as wild-type MEFs despite increased cdk4 activity. In vivo, germline deficiency of p16Ink4a and p18Ink4c resulted in increased proliferation in the intermediate pituitary and pancreatic islets of adult mice, and survival of p16Ink4a-/-;p18Ink4c-/- mice was significantly reduced due to aggressive pituitary tumors. Compensation among the Ink4 proteins was observed both in vivo in p18Ink4c-/- mice and in MEFs from p16 Ink4a-/-, p18Ink4c-/-, or p16Ink4a-/-;p18 Ink4c-/- mice. Treatment with PD 0332991, a specific cdk4/6 kinase inhibitor, abrogated proliferation in those compartments where Ink4 deficiency was associated with enhanced proliferation (i.e., islets, pituitary, and B lymphocytes) but had no effect on proliferation in other tissues such as the small bowel. These data suggest that p16Ink4a and p18Ink4c coordinately regulate the in vivo catalytic activity of cdk4/6 in specific compartments of adult mice.

Original languageEnglish
Pages (from-to)4732-4741
Number of pages10
JournalCancer Research
Volume67
Issue number10
DOIs
StatePublished - May 15 2007
Externally publishedYes

Fingerprint

Cyclin-Dependent Kinase 6
Cyclin-Dependent Kinase 4
Cyclin D
Neoplasms
Cyclin E
Cyclin-Dependent Kinases
Pituitary Neoplasms
Islets of Langerhans
S Phase
Cell Cycle
Proteins
B-Lymphocytes
Phosphotransferases
Embryonic Structures
Fibroblasts
Phosphorylation
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Ramsey, M. R., Krishnamurthy, J., Pei, X-H., Torrice, C., Lin, W., Carrasco, D. R., ... Sharpless, N. E. (2007). Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. Cancer Research, 67(10), 4732-4741. https://doi.org/10.1158/0008-5472.CAN-06-3437

Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. / Ramsey, Matthew R.; Krishnamurthy, Janakiraman; Pei, Xin-Hai; Torrice, Chad; Lin, Weili; Carrasco, Daniel R.; Ligon, Keith L.; Xiong, Yue; Sharpless, Norman E.

In: Cancer Research, Vol. 67, No. 10, 15.05.2007, p. 4732-4741.

Research output: Contribution to journalArticle

Ramsey, MR, Krishnamurthy, J, Pei, X-H, Torrice, C, Lin, W, Carrasco, DR, Ligon, KL, Xiong, Y & Sharpless, NE 2007, 'Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues', Cancer Research, vol. 67, no. 10, pp. 4732-4741. https://doi.org/10.1158/0008-5472.CAN-06-3437
Ramsey, Matthew R. ; Krishnamurthy, Janakiraman ; Pei, Xin-Hai ; Torrice, Chad ; Lin, Weili ; Carrasco, Daniel R. ; Ligon, Keith L. ; Xiong, Yue ; Sharpless, Norman E. / Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues. In: Cancer Research. 2007 ; Vol. 67, No. 10. pp. 4732-4741.
@article{512b12b6d9464a2e90fce0af2bd7ad61,
title = "Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues",
abstract = "Cell cycle progression from G1 to S phase depends on phosphorylation of pRb by complexes containing a cyclin (D type or E type) and cyclin-dependent kinase (e.g., cdk2, cdk4, or cdk6). Ink4 proteins function to oppose the action of cdk4/ 6-cyclin D complexes by inhibiting cdk4/6. We employed genetic and pharmacologic approaches to study the interplay among Ink4 proteins and cdk4/6 activity in vivo. Mouse embryo fibroblasts (MEF) lacking p16Ink4a and p18Ink4c showed similar growth kinetics as wild-type MEFs despite increased cdk4 activity. In vivo, germline deficiency of p16Ink4a and p18Ink4c resulted in increased proliferation in the intermediate pituitary and pancreatic islets of adult mice, and survival of p16Ink4a-/-;p18Ink4c-/- mice was significantly reduced due to aggressive pituitary tumors. Compensation among the Ink4 proteins was observed both in vivo in p18Ink4c-/- mice and in MEFs from p16 Ink4a-/-, p18Ink4c-/-, or p16Ink4a-/-;p18 Ink4c-/- mice. Treatment with PD 0332991, a specific cdk4/6 kinase inhibitor, abrogated proliferation in those compartments where Ink4 deficiency was associated with enhanced proliferation (i.e., islets, pituitary, and B lymphocytes) but had no effect on proliferation in other tissues such as the small bowel. These data suggest that p16Ink4a and p18Ink4c coordinately regulate the in vivo catalytic activity of cdk4/6 in specific compartments of adult mice.",
author = "Ramsey, {Matthew R.} and Janakiraman Krishnamurthy and Xin-Hai Pei and Chad Torrice and Weili Lin and Carrasco, {Daniel R.} and Ligon, {Keith L.} and Yue Xiong and Sharpless, {Norman E.}",
year = "2007",
month = "5",
day = "15",
doi = "10.1158/0008-5472.CAN-06-3437",
language = "English",
volume = "67",
pages = "4732--4741",
journal = "Journal of Cancer Research",
issn = "0099-7013",
publisher = "American Association for Cancer Research Inc.",
number = "10",

}

TY - JOUR

T1 - Expression of p16Ink4a compensates for p18Ink4c loss in cyclin-dependent kinase 4/6-dependent tumors and tissues

AU - Ramsey, Matthew R.

AU - Krishnamurthy, Janakiraman

AU - Pei, Xin-Hai

AU - Torrice, Chad

AU - Lin, Weili

AU - Carrasco, Daniel R.

AU - Ligon, Keith L.

AU - Xiong, Yue

AU - Sharpless, Norman E.

PY - 2007/5/15

Y1 - 2007/5/15

N2 - Cell cycle progression from G1 to S phase depends on phosphorylation of pRb by complexes containing a cyclin (D type or E type) and cyclin-dependent kinase (e.g., cdk2, cdk4, or cdk6). Ink4 proteins function to oppose the action of cdk4/ 6-cyclin D complexes by inhibiting cdk4/6. We employed genetic and pharmacologic approaches to study the interplay among Ink4 proteins and cdk4/6 activity in vivo. Mouse embryo fibroblasts (MEF) lacking p16Ink4a and p18Ink4c showed similar growth kinetics as wild-type MEFs despite increased cdk4 activity. In vivo, germline deficiency of p16Ink4a and p18Ink4c resulted in increased proliferation in the intermediate pituitary and pancreatic islets of adult mice, and survival of p16Ink4a-/-;p18Ink4c-/- mice was significantly reduced due to aggressive pituitary tumors. Compensation among the Ink4 proteins was observed both in vivo in p18Ink4c-/- mice and in MEFs from p16 Ink4a-/-, p18Ink4c-/-, or p16Ink4a-/-;p18 Ink4c-/- mice. Treatment with PD 0332991, a specific cdk4/6 kinase inhibitor, abrogated proliferation in those compartments where Ink4 deficiency was associated with enhanced proliferation (i.e., islets, pituitary, and B lymphocytes) but had no effect on proliferation in other tissues such as the small bowel. These data suggest that p16Ink4a and p18Ink4c coordinately regulate the in vivo catalytic activity of cdk4/6 in specific compartments of adult mice.

AB - Cell cycle progression from G1 to S phase depends on phosphorylation of pRb by complexes containing a cyclin (D type or E type) and cyclin-dependent kinase (e.g., cdk2, cdk4, or cdk6). Ink4 proteins function to oppose the action of cdk4/ 6-cyclin D complexes by inhibiting cdk4/6. We employed genetic and pharmacologic approaches to study the interplay among Ink4 proteins and cdk4/6 activity in vivo. Mouse embryo fibroblasts (MEF) lacking p16Ink4a and p18Ink4c showed similar growth kinetics as wild-type MEFs despite increased cdk4 activity. In vivo, germline deficiency of p16Ink4a and p18Ink4c resulted in increased proliferation in the intermediate pituitary and pancreatic islets of adult mice, and survival of p16Ink4a-/-;p18Ink4c-/- mice was significantly reduced due to aggressive pituitary tumors. Compensation among the Ink4 proteins was observed both in vivo in p18Ink4c-/- mice and in MEFs from p16 Ink4a-/-, p18Ink4c-/-, or p16Ink4a-/-;p18 Ink4c-/- mice. Treatment with PD 0332991, a specific cdk4/6 kinase inhibitor, abrogated proliferation in those compartments where Ink4 deficiency was associated with enhanced proliferation (i.e., islets, pituitary, and B lymphocytes) but had no effect on proliferation in other tissues such as the small bowel. These data suggest that p16Ink4a and p18Ink4c coordinately regulate the in vivo catalytic activity of cdk4/6 in specific compartments of adult mice.

UR - http://www.scopus.com/inward/record.url?scp=34250372017&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34250372017&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-06-3437

DO - 10.1158/0008-5472.CAN-06-3437

M3 - Article

C2 - 17510401

AN - SCOPUS:34250372017

VL - 67

SP - 4732

EP - 4741

JO - Journal of Cancer Research

JF - Journal of Cancer Research

SN - 0099-7013

IS - 10

ER -